DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Overman MJ, Kopetz S, McDermott RS, Aglietta M, Chen F, Gelsomino F. et al.
Nivolumab in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Long-term survival according to prior treatment from CheckMate-142 [ASCO GI abstract 554].
J Clin Oncol 2018:36(Suppl 4S)
We do not assume any responsibility for the contents of the web pages of other providers.